KIN - Kindred Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
4,181
1,966
-
-
Cost of Revenue
614
324
-
-
Gross Profit
3,567
1,642
-
-
Operating Expenses
Research Development
28,932
26,399
17,665
13,861
Selling General and Administrative
37,567
26,499
13,988
8,308
Total Operating Expenses
66,499
52,898
31,653
22,169
Operating Income or Loss
-62,932
-51,256
-31,653
-22,169
Interest Expense
-
-
-
-
Total Other Income/Expenses Net
-
-
-
-655
Income Before Tax
-61,096
-49,690
-30,879
-22,499
Income Tax Expense
-
-
-
-
Income from Continuing Operations
-61,096
-49,690
-30,879
-22,499
Net Income
-61,096
-49,690
-30,879
-22,499
Net Income available to common shareholders
-61,096
-49,690
-30,879
-22,499
Reported EPS
Basic
-
-1.60
-1.23
-1.13
Diluted
-
-1.60
-1.23
-1.13
Weighted average shares outstanding
Basic
-
31,001
25,084
19,873
Diluted
-
31,001
25,084
19,873
EBITDA
-
-50,451
-31,178
-22,014